ADAM RHODES: Open Payments
NPI 1932526332 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 9 payments from 9 companies in 2025. Trend: 2023 $2,418 · 2024 $826 · 2025 $327
Food & beverage: $253Education: $74
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $116 |
| Regeneron Healthcare Solutions, Inc. | 1 | $74 |
| ABBVIE INC. | 1 | $42 |
| LEO Pharma Inc. | 1 | $28 |
| UCB, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Galderma Laboratories, L.P. | 1 | $14 |
| Organon LLC | 1 | $6 |
Products named: OTEZLA, DUPIXENT, RINVOQ, ANZUPGO, Bimzelx, COSENTYX, EBGLYSS, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
